Persistence of IgG response to SARS-CoV-2

Affiliations

¹ Department of Epidemiology and Public Health, Sciensano, 1050 Brussels, Belgium. Electronic address: elza.duysburgh@sciensano.be.
² Department of Epidemiology and Public Health, Sciensano, 1050 Brussels, Belgium; European Programme for Intervention Epidemiology Training, European Centre for Disease Prevention and Control, Stockholm, Sweden.
³ Department of Infectious Diseases in Humans, Sciensano, 1050 Brussels, Belgium.
⁴ Department of Infectious Diseases in Humans, Sciensano, 1050 Brussels, Belgium; European Public Health Microbiology Training, European Centre for Disease Prevention and Control, Stockholm, Sweden.
⁵ Department of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.
⁶ Department of Public Health, Institute of Tropical Medicine, Antwerp, Belgium.
⁷ Department of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, Belgium; Department of Biomedical Sciences, University of Antwerp, Antwerp, Belgium.

Els Duysburgh et al. Lancet Infect Dis. 2021 Feb.

. 2021 Feb;21(2):163-164.

doi: 10.1016/S1473-3099(20)30943-9. Epub 2020 Dec 17.

¹ Department of Epidemiology and Public Health, Sciensano, 1050 Brussels, Belgium. Electronic address: elza.duysburgh@sciensano.be.
² Department of Epidemiology and Public Health, Sciensano, 1050 Brussels, Belgium; European Programme for Intervention Epidemiology Training, European Centre for Disease Prevention and Control, Stockholm, Sweden.
³ Department of Infectious Diseases in Humans, Sciensano, 1050 Brussels, Belgium.
⁴ Department of Infectious Diseases in Humans, Sciensano, 1050 Brussels, Belgium; European Public Health Microbiology Training, European Centre for Disease Prevention and Control, Stockholm, Sweden.
⁵ Department of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.
⁶ Department of Public Health, Institute of Tropical Medicine, Antwerp, Belgium.
⁷ Department of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, Belgium; Department of Biomedical Sciences, University of Antwerp, Antwerp, Belgium.

Erratum in

Correction to Lancet Infect Dis 2020; published online Dec 17. https://doi.org/10.1016/S1473-3099(20)30943-9.
[No authors listed] [No authors listed] Lancet Infect Dis. 2021 Mar;21(3):e36. doi: 10.1016/S1473-3099(20)30989-0. Epub 2020 Dec 24. Lancet Infect Dis. 2021. PMID: 33357506 Free PMC article. No abstract available.
Correction to Lancet Infect Dis 2021; 21: 163-64.
[No authors listed] [No authors listed] Lancet Infect Dis. 2021 Feb;21(2):e16. doi: 10.1016/S1473-3099(21)00017-7. Lancet Infect Dis. 2021. PMID: 33515528 Free PMC article. No abstract available.

No abstract available

1. Gudbjartsson DF, Norddahl GL, Melsted P, et al. Humoral immune response to SARS-CoV-2 in Iceland. N Engl J Med. 2020;383:1724–1734. - PMC - PubMed
1. Wajnberg A, Amanat F, Firpo A, et al. Robust neutralizing antibodies to SARS-CoV-2 infection persist for months. Science. 2020 doi: 10.1126/science.abd7728. published online Oct 28. - DOI - PMC - PubMed
1. Ibarrondo FJ, Fulcher JA, Goodman-Meza D, et al. Rapid decay of anti-SARS-CoV-2 antibodies in persons with mild COVID-19. N Engl J Med. 2020;383:1085–1087. - PMC - PubMed
1. Seow J, Graham C, Merrick B, et al. Longitudinal observation and decline of neutralizing antibody responses in the three months following SARS-CoV-2 infection in humans. Nat Microbiol. 2020;5:1598–1607. - PMC - PubMed
1. Ward H, Cooke G, Atchison C, et al. Declining prevalence of antibody positivity to SARS-CoV-2: a community study of 365,000 adults. medRxiv. 2020 doi: 10.1101/2020.10.26.20219725. published online Oct 27. (preprint) - DOI